Park KS

References (5)

Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654
Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW
Ref : Diabetes Obes Metab , 19 :654 , 2017
PubMedID: 28058750

Title : Structure determination and quantification of a new flavone glycoside with anti-acetylcholinesterase activity from the herbs of Elsholtzia ciliata - Nugroho_2017_Nat.Prod.Res__1
Author(s) : Nugroho A , Park JH , Choi JS , Park KS , Hong JP , Park HJ
Ref : Nat Prod Res , :1 , 2017
PubMedID: 29224362

Title : Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension - Jin_2015_Diabetes.Obes.Metab_17_511
Author(s) : Jin SM , Park SW , Yoon KH , Min KW , Song KH , Park KS , Park JY , Park IB , Chung CH , Baik SH , Choi SH , Lee HW , Lee IK , Kim DM , Lee MK
Ref : Diabetes Obes Metab , 17 :511 , 2015
PubMedID: 25523633

Title : A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes - Yang_2015_Endocr.J_62_449
Author(s) : Yang HK , Min KW , Park SW , Chung CH , Park KS , Choi SH , Song KH , Kim DM , Lee MK , Sung YA , Baik SH , Kim IJ , Cha BS , Park JH , Ahn YB , Lee IK , Yoo SJ , Kim J , Park Ie B , Park TS , Yoon KH
Ref : Endocrine Journal , 62 :449 , 2015
PubMedID: 25819061

Title : Novel functional Renilla luciferase mutant provides long-term serum stability and high luminescence activity - Song_2013_Protein.Expr.Purif_91_215
Author(s) : Song WC , Sung HJ , Park KS , Choi JW , Cho JY , Um SH
Ref : Protein Expr Purif , 91 :215 , 2013
PubMedID: 23973867